KalVista Pharmaceuticals, Inc. (KALV) Depreciation, Depletion and Amortization USD 2014 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Summary
KalVista Pharmaceuticals, Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from 2014 to 2023.
  • KalVista Pharmaceuticals, Inc. Depreciation, Depletion and Amortization for the quarter ending July 31, 2023 was $193 K, a 22.2% increase year-over-year.
  • KalVista Pharmaceuticals, Inc. annual Depreciation, Depletion and Amortization for 2022 was $718 K, a 27.3% increase from 2021.
  • KalVista Pharmaceuticals, Inc. annual Depreciation, Depletion and Amortization for 2021 was $564 K, a 5.03% increase from 2020.
  • KalVista Pharmaceuticals, Inc. annual Depreciation, Depletion and Amortization for 2020 was $537 K, a 4.88% increase from 2019.
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $193 K +$35 K +22.2% May 1, 2023 Jul 31, 2023 10-Q 2023-09-07
Q2 2022 $158 K +$26 K +19.7% May 1, 2022 Jul 31, 2022 10-Q 2023-09-07
Q2 2021 $132 K +$4 K +3.13% May 1, 2021 Jul 31, 2021 10-Q 2022-09-08
Q2 2020 $128 K +$7 K +5.79% May 1, 2020 Jul 31, 2020 10-Q 2021-09-09
Q2 2019 $121 K +$71 K +142% May 1, 2019 Jul 31, 2019 10-Q 2020-09-14
Q2 2018 $50 K +$18 K +56.3% May 1, 2018 Jul 31, 2018 10-Q 2019-09-09
Q2 2017 $32 K +$24 K +300% May 1, 2017 Jul 31, 2017 10-Q 2018-09-14
Q2 2016 $8 K May 1, 2016 Jul 31, 2016 10-Q 2017-09-14
Q1 2016 $34 K +$3 K +9.68% Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-12
Q1 2015 $31 K +$21 K +210% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q1 2014 $10 K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.